 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Target Tuberculosis |
| Street 1: | Refuge House |
| Street 2: | 49-50 North Street |
| City: | Brighton |
| Province: | |
| Post Code: | BN1 1RH |
| Country: | United Kingdom of Great Britain and Northern Ireland |
| Phone: | 441273827070 |
| Organization Email: | info@targettb.org.uk |
| Web Site: | http://www.targettb.org.uk |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| OUR VISION: A world free from TB OUR MISSION: To stop vulnerable people in Africa and Asia dying frmo TB by improving access to information, treatment, care and support. Target TB was established in 2003 in recognition of the worldwide emergency caused by TB. Target TB focuses its work on supporting some of the poorest and most vulnerable people in Africa and Asia to access quality TB testing, treatment and vital additional support services. Strategic aims for 2012-15 are to: 1. Improve communities health seeking behaviour and reduce stigma and discrimination 2. Improve access to quality TB screening and diagnostic facilities 3. Improve access to quality TB treatment and community based support to maximise cure and completion rates 4. Increase knowledge and skills of volunteers and health workers in order to provide high quality services 5. Promote and improve the integration of TB control into other health and development responses 6. Influence policy and strengthen health systems to bring about long term sustainable improvements in TB control |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 6 - 10 |
| How did you hear about the Stop TB Partnership: | Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | United Kingdom |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Whilst Target TB's work is primarily focused in the developing world, we are involved in raising awareness about the global epidemic within the UK, and lobbying for investment in TB control with UK policy and decision makers. | |
Geographical Reach | |
| Which country is your headquarters located in: | United Kingdom of Great Britain and Northern Ireland |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Democratic Republic of Timor-Leste India Malawi South Africa Uganda Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Target TB's work with its local grass roots organisations in Africa and Asia specifically focuses on mobilising and supporting community volunteers who do outreach at the community level to identify people with TB symptoms, and link them up to quality diagnostic services as soon as possible. The community volunteers are trained as DOTS volunteers and provide high quality DOTS support throughout treatment to support high cure/completion rates in their local communities. Drug-Resistant TB: Target TB's partners are involved in identifying MDR-TB suspects through their close working with comunities and local health services, helping those suspected with drug-resistant TB to access relevant testing services. Target TB also supports MDR-TB treatment through two partner organisations in India and Timor-Leste who operate recognised DOTS Plus treatment services, in collaboration with NTPs. TB-HIV: Target TB mainstreams TB/HIV integration throughout all its work, and expects partner organisations working on TB to identify and provide appropriate responses to co-infection. In particular our work in Southern Africa involves a high degree of TB/HIV integrated activities - e.g. ensuring TB information is given to HIV positive people, supporting screening of HIV positive people for TB, helping TB/HIV co-infected people access ART, providing home-based care services for co-infected patients New Diagnostics: Target TB has supported a project in Uganda to trial the use of MOT as a more effective diagnostic tool in a high HIV, high poverty setting, comparing the cost and effectiveness of MOT with MGIT. As the trial proved very successful MOT is being utilised within Target TB's supported urban slums project, enabling TB suspects to benefit from this more sensitive diagnostic technique Research: Target TB has carried out operational research of its community based TB programme in South India, to demonstrate the effectiveness and sustainability of community based TB control. Target TB is also currently carrying out research into the vulnerability of urban slum communities in Uganda to TB, to help plan its programmatic approaches in these communities. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | June 23, 2014 |